U.S. Chamber Decries FDA’s Proposed Rule on Generic Prescription Drug Labeling

11-11-2013 Business Wire HealthComments (0)


-Lisa A. Rickard, president of the U.S. Chamber Institute for Legal Reform (ILR), made the following statement today decrying the Food and Drug Administration’s (FDA) proposed rule abandoning its requirement that generic drugs carry warning labels identical to those on name brand equivalents. “The FDA’s proposal writes a prescription for mega lawsuits against generic drug makers by plaintiffs’ lawyers alleging that generic labels are somehow inadequate. “The proposed

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top